导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.45% | 2084/4773 |
| 近一周 | -2.71% | 2909/5462 |
| 近一月 | -6.46% | 3534/5421 |
| 近一季 | -11.07% | 3651/5209 |
| 近半年 | -5.10% | 2734/4920 |
| 近一年 | 4.95% | 1650/4366 |
| 近两年 | 64.60% | 1084/2954 |
| 近三年 | 34.22% | 892/2253 |
| 成立以来 | 387.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.28% 1747/4961 |
18.21% 1406/5312 |
- - |
- - |
| 2025 | 31.78% 1217/4813 |
3.07% 1208/3635 |
0.14% 2752/4076 |
29.11% 1236/4524 |
-1.10% 2825/4813 |
| 2024 | 8.36% 1563/3463 |
-3.82% 1567/2808 |
-0.96% 878/3014 |
15.42% 1721/3129 |
-1.44% 1702/3463 |
| 2023 | -16.73% 1697/2656 |
5.77% 756/2280 |
-6.46% 1647/2385 |
-10.30% 1982/2515 |
-6.17% 1654/2655 |
| 2022 | -25.86% 1353/2207 |
-18.61% 1360/1919 |
9.28% 289/2016 |
-16.45% 1457/2113 |
-0.24% 1582/2208 |
| 2021 | 5.76% 535/1822 |
-6.74% 1034/1255 |
11.92% 355/1330 |
-4.60% 724/1466 |
6.21% 226/1822 |
| 2020 | 44.90% 222/1250 |
-1.97% 250/1028 |
23.81% 185/1067 |
8.37% 717/1164 |
10.16% 612/1184 |
| 2019 | 41.42% 231/1092 |
35.37% 95/754 |
-10.17% 718/804 |
5.55% 144/850 |
10.18% 155/918 |
| 2018 | -37.03% 592/834 |
- - |
- - |
- - |
-17.68% 653/691 |
| 2017 | 17.16% 230/714 |
- - |
- - |
- - |
- - |
| 2016 | -20.75% 447/605 |
- - |
- - |
- - |
- - |
| 2015 | 54.61% 14/575 |
- - |
- - |
- - |
- - |
| 2014 | 9.27% 210/237 |
- - |
- - |
- - |
- - |
| 2013 | 17.90% 18/186 |
- - |
- - |
- - |
- - |
| 2012 | -1.24% 128/140 |
- - |
- - |
- - |
- - |
| 2011 | -36.71% 102/102 |
- - |
- - |
- - |
- - |
| 2010 | 20.71% 1/58 |
- - |
- - |
- - |
- - |
| 2009 | 94.53% 4/27 |
- - |
- - |
- - |
- - |
| 2008 | -52.62% 5/26 |
- - |
- - |
- - |
- - |
| 2007 | 149.25% 6/22 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华夏中小企业100ETF VS. 长安沪深300非周期A(740101) |